| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |